13 Oct 2014 - 17 Oct 2014

Drug Safety of Stem Cells and other Novel Therapeutics (course 1.2), Liverpool (UK)

This course will introduce the emerging area of the safety science of the therapeutic application of stem cells, and will address all the key issues that need to be considered by developers of these therapies, including academics and the pharmaceutical/ biotech industry, as well as the important area of regulation. Other new areas of therapy will also be considered, such as genetically-engineered cells. The use of stem cells in the screening of conventional drugs for efficacy and particularly safety will also be investigated. UK and European leaders in these fields, from Industry, Academia and the Regulatory Agencies, will contribute teaching sessions in a small, informal and interactive learning environment. 

Organizer

SafeSciMET

Location

MRC Centre for Drug Safety Science Sherrington Building The University of Liverpool Ashton Street UK-Liverpool L69 3GE

Link to Event

http://www.safescimet.eu/registration/docs/brochure/course_brochure_134.pdf